Treatment of Papillomatosis of the Larynx with Transfer Factor

Abstract

Transfer factor was used in two patients with laryngeal papillomatosis in an attempt to influence the thymus dependent small lymphocytes to become immunologically effective in their attempt to control the lesions. Following transfer factor, therapy laboratory tests showed altered reactivity of the lymphocyte stimulation tests for delayed hypersensitivity, and the results of the in vitro lymphocyte cytotoxic assay suggested that transfer factor improved the ability of lymphocytes to kill the tumor cells. Clinically, a change in the skin responses to the tests of delayed hypersensitivity was observed, and a change in the endoscopic appearance of the lesions occurred. Histologically, the specimens showed a marked influx of immune cells when transfer factor was being administered. Finally there was a significant clinical improvement in the disease state.

Get full access to this article

View all access options for this article.

References

Straus

Shaw

Bunting

: Crystalline virus-like particles from skin papillomas characterized by intra-nuclear inclusion bodies. Proc Soc Exp Biol Med 72: 46–50, 1949.

Williams

Howatson

Almeida

: Morphological characterization of the virus of the human common wart. Nature 189: 895–897, 1961.

Almeida

Howatson

Williams

: Electron microscope study of human warts; sites of virus production and nature of the inclusion bodies. J Invest Dermatol 38: 337–345, 1962.

Murray

Hobbs

Payne

: Possible clonal origin of common warts (verruca vulgaris). Nature 232: 51–52, 1971.

Noyes

: Studies on the shope rabbit papilloma virus. II. The location of infective virus in papillomas of the cottontail rabbit. J Exp Med 109: 423–427, 1959.

Boyle

Riggs

Oshero

: Electron microscope identification of papova virus in laryngeal papilloma. Laryngoscope 83: 1102–1107, 1973.

Thomas, quoted by Lawrence

: Immunobiology. Good

Fisher

(eds), Connecticut, Sinauer Associates Inc. 1972, p 112.

Burnett

Sir : Self and Cellular Immunology, Book 1. New York, Cambridge University Press, 1969.

Landsteiner

Chase

: The Specificity of Serological Reaction. Cambridge, Mass., Harvard University Press, 1945.

10.

Lawrence

: Immunobiology, ed 4. Connecticut, Sinauer Associates Inc, 1972, p 104.

11.

Lawrence

: The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leukocytes. J Clin Invest 34: 219–230, 1955.

12.

Lawrence

Valentine

: Transfer factor in delayed hypersensitivity. Ann N Y Acad Sci 169: 269, 1970.

13.

Lynn

Spitler

Levin

: The Wiskott-Aldrich syndrome: The results of transfer factor therapy. J Clin Invest 51: 3216–3224, 1972.

14.

Fudenberg

Levin

Spitler

: The therapeutic uses of transfer factor. Hosp Pract 9: 95–104, 1974.

15.

Hellstrom

Sjogren

: Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer 7: 1–16, 1971.

16.

Jagarlamoody

Aust

Tew

: In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by radioisotopic technique. Proc Nat Acad Sci 68: 1346–1350, 1971.

17.

Quick

Behrens

: An in-vitro model for assay of cellular immunity of laryngeal papilloma. In preparation.

18.

Levin

Spitler

Stites

: Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency. Clinical and laboratory responses to therapy with transfer factor. Proc Nat Acad Sci 67: 2821–2828, 1970.

19.

DuPont

Ballow

Hansen

: Effect of transfer factor therapy on mixed lymphocyte culture reactivity. Proc Nat Acad Sci 71: 867–871, 1974.

20.

Tagami

Ogino

Takigawa

: Regression of plane warts following spontaneous inflammation. Br J Dermatol 90: 147–154, 1974.

21.

Matthews

Shirodaria

: Study of regression warts by immunofluoresence. Lancet 1: 689–691, 1973.